These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33814230)

  • 1. The impact of two-dose varicella vaccination on varicella and herpes zoster incidence in South Korea using a mathematical model with changing population demographics.
    Suh J; Lee T; Choi JK; Lee J; Park SH
    Vaccine; 2021 Apr; 39(18):2575-2583. PubMed ID: 33814230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in varicella and herpes zoster epidemiology before and after the implementation of universal one-dose varicella vaccination over one decade in South Korea, 2003-2015.
    Choi JK; Park SH; Park S; Choi SM; Kim SH; Lee DG; Yoo JH; Choi JH; Kang JH
    Hum Vaccin Immunother; 2019; 15(11):2554-2560. PubMed ID: 31008679
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of childhood varicella vaccination on the incidence of herpes zoster in the general population: modelling the effect of exogenous and endogenous varicella-zoster virus immunity boosting.
    Sauboin C; Holl K; Bonanni P; Gershon AA; Benninghoff B; Carryn S; Burgess MA; Wutzler P
    BMC Infect Dis; 2019 Feb; 19(1):126. PubMed ID: 30727971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway.
    Marchetti S; Guzzetta G; Flem E; Mirinaviciute G; Scalia Tomba G; Manfredi P
    Vaccine; 2018 Feb; 36(8):1116-1125. PubMed ID: 29366704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling study.
    Horn J; Damm O; Greiner W; Hengel H; Kretzschmar ME; Siedler A; Ultsch B; Weidemann F; Wichmann O; Karch A; Mikolajczyk RT
    BMC Med; 2018 Jan; 16(1):3. PubMed ID: 29316913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination.
    Horn J; Karch A; Damm O; Kretzschmar ME; Siedler A; Ultsch B; Weidemann F; Wichmann O; Hengel H; Greiner W; Mikolajczyk RT
    Hum Vaccin Immunother; 2016 Jul; 12(7):1766-76. PubMed ID: 26835890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of 2-dose routine measles, mumps, rubella, and varicella vaccination in France on the epidemiology of varicella and zoster using a dynamic model with an empirical contact matrix.
    Ouwens MJ; Littlewood KJ; Sauboin C; Téhard B; Denis F; Boëlle PY; Alain S
    Clin Ther; 2015 Apr; 37(4):816-829.e10. PubMed ID: 25726457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England.
    van Hoek AJ; Melegaro A; Zagheni E; Edmunds WJ; Gay N
    Vaccine; 2011 Mar; 29(13):2411-20. PubMed ID: 21277405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster.
    Brisson M; Melkonyan G; Drolet M; De Serres G; Thibeault R; De Wals P
    Vaccine; 2010 Apr; 28(19):3385-97. PubMed ID: 20199763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling varicella vaccination - What does a lack of surge in herpes zoster incidence tell us about exogenous boosting?
    Widgren K; Tomba GS; Leung KY; Giesecke J
    Vaccine; 2022 Jan; 40(4):673-681. PubMed ID: 34930603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point-Counterpoint: The Hope-Simpson Hypothesis and Its Implications Regarding an Effect of Routine Varicella Vaccination on Herpes Zoster Incidence.
    Harpaz R; van Hoek AJ
    J Infect Dis; 2018 Sep; 218(suppl_2):S57-S62. PubMed ID: 30247602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster.
    van Lier A; Lugnér A; Opstelten W; Jochemsen P; Wallinga J; Schellevis F; Sanders E; de Melker H; van Boven M
    EBioMedicine; 2015 Oct; 2(10):1494-9. PubMed ID: 26629544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
    Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
    Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom.
    van Hoek AJ; Melegaro A; Gay N; Bilcke J; Edmunds WJ
    Vaccine; 2012 Feb; 30(6):1225-34. PubMed ID: 22119592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of demographic changes, exogenous boosting and new vaccination policies on varicella and herpes zoster in Italy: a modelling and cost-effectiveness study.
    Melegaro A; Marziano V; Del Fava E; Poletti P; Tirani M; Rizzo C; Merler S
    BMC Med; 2018 Jul; 16(1):117. PubMed ID: 30012132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries.
    Damm O; Ultsch B; Horn J; Mikolajczyk RT; Greiner W; Wichmann O
    BMC Public Health; 2015 Jun; 15():533. PubMed ID: 26041469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of universal varicella vaccination in Turkey using a dynamic transmission model.
    Wolfson LJ; Daniels VJ; Pillsbury M; Kurugöl Z; Yardimci C; Kyle J; Dinleyici EC
    PLoS One; 2019; 14(8):e0220921. PubMed ID: 31408505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of pediatric herpes zoster after varicella infection: a population-based study.
    Wen SY; Liu WL
    Pediatrics; 2015 Mar; 135(3):e565-71. PubMed ID: 25713285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Waning Effectiveness of One-dose Universal Varicella Vaccination in Korea, 2011-2018: a Propensity Score Matched National Population Cohort.
    Hong K; Sohn S; Choe YJ; Rhie K; Lee JK; Han MS; Chun BC; Choi EH
    J Korean Med Sci; 2021 Sep; 36(36):e222. PubMed ID: 34519184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Universal varicella vaccination increased the incidence of herpes zoster in the child-rearing generation as its short-term effect.
    Toyama N; Shiraki K;
    J Dermatol Sci; 2018 Oct; 92(1):89-96. PubMed ID: 30041832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.